tradingkey.logo

National Research Corp

NRC
19.010USD
+0.130+0.69%
Fechamento 12/23, 16:00ETCotações atrasadas em 15 min
430.72MValor de mercado
26.72P/L TTM

National Research Corp

19.010
+0.130+0.69%

Mais detalhes de National Research Corp Empresa

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.

Informações de National Research Corp

Código da empresaNRC
Nome da EmpresaNational Research Corp
Data de listagemOct 01, 1997
CEOGreen (Trent S)
Número de funcionários368
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 01
Endereço1245 Q Street
CidadeLINCOLN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal68508
Telefone14024752525
Sitehttps://nrchealth.com/
Código da empresaNRC
Data de listagemOct 01, 1997
CEOGreen (Trent S)

Executivos da empresa National Research Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael D. Hays
Mr. Michael D. Hays
Chairman of the Board
Chairman of the Board
1.39M
+1326.95%
Mr. Andrew (Andy) Monnich
Mr. Andrew (Andy) Monnich
Chief Corporate Development Officer
Chief Corporate Development Officer
100.00K
--
Mr. John N. Nunnelly
Mr. John N. Nunnelly
Lead Independent Director
Lead Independent Director
32.67K
--
Dr. Donald M. Berwick
Dr. Donald M. Berwick
Independent Director
Independent Director
--
--
Ms. Parul Bhandari
Ms. Parul Bhandari
Independent Director
Independent Director
--
--
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Penny A. Wheeler
Dr. Penny A. Wheeler
Independent Director
Independent Director
--
--
Ms. Helen L. Hrdy
Ms. Helen L. Hrdy
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Trent Green
Mr. Trent Green
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Shane Harrison
Mr. Shane Harrison
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael D. Hays
Mr. Michael D. Hays
Chairman of the Board
Chairman of the Board
1.39M
+1326.95%
Mr. Andrew (Andy) Monnich
Mr. Andrew (Andy) Monnich
Chief Corporate Development Officer
Chief Corporate Development Officer
100.00K
--
Mr. John N. Nunnelly
Mr. John N. Nunnelly
Lead Independent Director
Lead Independent Director
32.67K
--
Dr. Donald M. Berwick
Dr. Donald M. Berwick
Independent Director
Independent Director
--
--
Ms. Parul Bhandari
Ms. Parul Bhandari
Independent Director
Independent Director
--
--
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2024
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
143.06M
0.00%
Canada
0.00
0.00%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: qui, 13 de nov
Atualizado em: qui, 13 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Amandla MK Trust
20.99%
Common Property Trust LLC
17.01%
Kayne Anderson Rudnick Investment Management, LLC
12.14%
Hays (Michael D)
6.12%
The Vanguard Group, Inc.
4.07%
Outro
39.68%
Investidores
Investidores
Proporção
Amandla MK Trust
20.99%
Common Property Trust LLC
17.01%
Kayne Anderson Rudnick Investment Management, LLC
12.14%
Hays (Michael D)
6.12%
The Vanguard Group, Inc.
4.07%
Outro
39.68%
Tipos de investidores
Investidores
Proporção
Corporation
38.01%
Investment Advisor
33.07%
Investment Advisor/Hedge Fund
11.63%
Individual Investor
10.45%
Hedge Fund
2.52%
Research Firm
1.47%
Bank and Trust
0.49%
Pension Fund
0.39%
Family Office
0.32%
Outro
1.65%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
316
11.69M
51.61%
-1.72M
2025Q2
316
22.53M
97.50%
+275.13K
2025Q1
320
21.76M
95.48%
-548.18K
2024Q4
315
20.82M
90.17%
-2.30M
2024Q3
309
21.08M
90.40%
-2.26M
2024Q2
296
21.32M
90.56%
-1.95M
2024Q1
278
21.70M
92.11%
-771.36K
2023Q4
273
22.27M
90.65%
-614.52K
2023Q3
268
22.27M
90.62%
-349.69K
2023Q2
265
21.82M
88.76%
-772.36K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Amandla MK Trust
4.76M
20.62%
--
--
Mar 20, 2025
Common Property Trust LLC
3.85M
16.71%
--
--
Mar 20, 2025
Kayne Anderson Rudnick Investment Management, LLC
2.99M
12.95%
-37.78K
-1.25%
Jun 30, 2025
Hays (Michael D)
1.39M
6.01%
+1.29M
+1326.95%
Mar 20, 2025
The Vanguard Group, Inc.
919.55K
3.99%
-13.43K
-1.44%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
862.15K
3.74%
-82.29K
-8.71%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
704.75K
3.06%
-48.68K
-6.46%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
531.20K
2.3%
-23.09K
-4.17%
Jun 30, 2025
Green (Trent S.)
500.00K
2.17%
+500.00K
--
Jun 01, 2025
Geode Capital Management, L.L.C.
404.30K
1.75%
-42.27K
-9.47%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Acquirers Small and Micro Deep Value ETF
0.85%
RiverFront Dynamic US Dividend Advantage ETF
0.66%
Lattice Hartford Multifactor Small Cap ETF
0.25%
Royce Quant Small-Cap Quality Value ETF
0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.16%
WisdomTree US SmallCap Quality Dividend Growth
0.13%
WisdomTree U.S. SmallCap Dividend Fund
0.07%
WisdomTree US SmallCap Fund
0.05%
Franklin US Small Cap Multifactor Index ETF
0.03%
iShares Micro-Cap ETF
0.03%
Ver Mais
Acquirers Small and Micro Deep Value ETF
Proporção0.85%
RiverFront Dynamic US Dividend Advantage ETF
Proporção0.66%
Lattice Hartford Multifactor Small Cap ETF
Proporção0.25%
Royce Quant Small-Cap Quality Value ETF
Proporção0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporção0.16%
WisdomTree US SmallCap Quality Dividend Growth
Proporção0.13%
WisdomTree U.S. SmallCap Dividend Fund
Proporção0.07%
WisdomTree US SmallCap Fund
Proporção0.05%
Franklin US Small Cap Multifactor Index ETF
Proporção0.03%
iShares Micro-Cap ETF
Proporção0.03%

Dividendo

Um total de 88.46M USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Oct 27, 2025
NRC.NB Final Cash Dividend of gross USD 0.16 paid on Jan 09, 2026 going ex on Dec 26, 2025
Dec 26, 2025
Jan 09, 2026
Dec 26, 2025
Jul 28, 2025
NRC.NB Interim Cash Dividend of gross USD 0.12 paid on Oct 10, 2025 going ex on Sep 26, 2025
Sep 26, 2025
Oct 10, 2025
Sep 26, 2025
Apr 28, 2025
NRC.NB Interim Cash Dividend of gross USD 0.12 paid on Jul 11, 2025 going ex on Jun 27, 2025
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 24, 2025
NRC.NB Interim Cash Dividend of gross USD 0.12 paid on Apr 11, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Oct 25, 2024
NRC.NB Final Cash Dividend of gross USD 0.12 paid on Jan 10, 2025 going ex on Dec 27, 2024
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 06, 2024
NRC.NB Interim Cash Dividend of gross USD 0.12 paid on Oct 11, 2024 going ex on Sep 27, 2024
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 07, 2024
NRC.NB Interim Cash Dividend of gross USD 0.12 paid on Jul 15, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 15, 2024
Jun 28, 2024
Feb 13, 2024
NRC.NB Interim Cash Dividend of gross USD 0.12 paid on Apr 15, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 15, 2024
Mar 27, 2024
Nov 17, 2023
NRC.NB Final Cash Dividend of gross USD 0.12 paid on Jan 12, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 12, 2024
Dec 28, 2023
Aug 21, 2023
NRC.NB Interim Cash Dividend of gross USD 0.12 paid on Oct 13, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 13, 2023
Sep 28, 2023
Ver Mais

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados

Perguntas frequentes

Quem são os cinco principais acionistas de National Research Corp?

Os cinco principais acionistas de National Research Corp são:
Amandla MK Trust detém 4.76M Ações, representando 20.62% do total de Ações.
Common Property Trust LLC detém 3.85M Ações, representando 16.71% do total de Ações.
Kayne Anderson Rudnick Investment Management, LLC detém 2.99M Ações, representando 12.95% do total de Ações.
Hays (Michael D) detém 1.39M Ações, representando 6.01% do total de Ações.
The Vanguard Group, Inc. detém 919.55K Ações, representando 3.99% do total de Ações.

Quais são os três principais tipos de acionistas de National Research Corp?

Os três principais tipos de acionistas da National Research Corp são:
Amandla MK Trust
Common Property Trust LLC
Kayne Anderson Rudnick Investment Management, LLC

Quantas instituições possuem ações da National Research Corp (NRC)?

Em 2025Q3, 316 instituições possuíam ações da National Research Corp, com valor de mercado aproximado de 11.69M, representando 51.61% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em -45.89%.

Qual é a maior fonte de receita da National Research Corp?

Em FY2024, o segmento de negócios -- gerou a maior receita para National Research Corp, totalizando -- e representando --% da receita total.
KeyAI